Endocrine tumours and neoplasia

A case of severe Cushing's disease in a treated non-functioning pituitary adenoma with difficult medical management

ea0007p78 | Endocrine tumours and neoplasia

Proliferation of colon cancer cell line and parathyroid hormone-related peptide gene

ea0007p79 | Endocrine tumours and neoplasia

Is there an ultra-short loop feedback of ACTH on itself?

ea0007p80 | Endocrine tumours and neoplasia

FSH-secreting pituitary gonadotroph adenoma producing ovarian hyperstimulation

ea0007p81 | Endocrine tumours and neoplasia

Deacetylating agents as mediators of iodide uptake and efflux in thyroid and breast

ea0007p82 | Endocrine tumours and neoplasia

Over-expression and over-activation of protein kinase B/Akt in human pituitary tumours

ea0007p83 | Endocrine tumours and neoplasia

An audit of acromegaly in North-East Scotland: increased use of medical therapy enables preservation of pituitary function

ea0007p84 | Endocrine tumours and neoplasia

The cyclin E specific F-box protein archipelago is over-expressed in pituitary tumours

ea0007p85 | Endocrine tumours and neoplasia

Urinary free metadrenalines provide the best diagnostic biochemical test for phaeochromocytoma; experience in a tertiary care centre

ea0007p86 | Endocrine tumours and neoplasia

A clinic for multiple endocrine neoplasia highlights needs for greater family awareness of type 1 MEN and for genetic testing of other family members

ea0007p87 | Endocrine tumours and neoplasia

Association between serum insulin-like growth factor-1 and serum growth hormone levels across an oral glucose tolerance test in assessing disease activity in acromegaly

ea0007p88 | Endocrine tumours and neoplasia

Ovarian stromal luteoma - a rare cause of postmenopausal virilization diagnosed by selective ovarian venous sampling

ea0007p89 | Endocrine tumours and neoplasia

The GnRH test in the assessment of patients with pituitary and parapituitary lesions. Results of a 5-year retrospective study

ea0007p90 | Endocrine tumours and neoplasia

Adrenal incidentalomas and insulin resistance - a simple coincidence or a complex syndrome?

ea0007p91 | Endocrine tumours and neoplasia

Should post hypophysectomy patients be discharged on steroids? The use of 0900h-cortisol measurements as a screening test for pituitary-adrenal dysfunction

ea0007p92 | Endocrine tumours and neoplasia

Inhibition of cell proliferation, but lack of antiangiogenic effect on GH-secreting pituitary adenomas treated with Lanreotide

ea0007p93 | Endocrine tumours and neoplasia

A new operation for adrenal pathology: laparoscopically-assisted mini-adrenalectomy

ea0007p94 | Endocrine tumours and neoplasia

Somatostatin and VEGF expression within the larynx

ea0007p95 | Endocrine tumours and neoplasia

The effects of surgery and tamoxifen on serum IGF-I and IGFBP3 levels in breast cancer

ea0007p96 | Endocrine tumours and neoplasia

Results of different primary treatment procedures for acromegalic patients

ea0007p97 | Endocrine tumours and neoplasia

Transcriptional silencing of the IGF-I receptor inhibits proliferation of MCF-7 breast cancer cells

ea0007p98 | Endocrine tumours and neoplasia

Diagnosis - 'query acromegaly'

ea0007p99 | Endocrine tumours and neoplasia

Factors determining remission of microprolactinomas after dopamine agonist withdrawal

ea0007p100 | Endocrine tumours and neoplasia

Pituitary tumor transforming gene (PTTG) regulates downstream angiogenic genes in thyroid cells

ea0007p101 | Endocrine tumours and neoplasia

Clinical studies of patients with neuroendocrine tumours (NETs)

ea0007p102 | Endocrine tumours and neoplasia

IGF-I and IGFBP-3 mRNA expression in tamoxifen-resistant, recurrent breast cancers

ea0007p103 | Endocrine tumours and neoplasia

IGF-I and IGFBP-3 mRNA expression in tamoxifen-resistant, recurrent breast cancers

ea0007p104 | Endocrine tumours and neoplasia

A somatostatin analogue and octreotide exert anti-proliferative effects on colonic cancer cells

ea0007p105 | Endocrine tumours and neoplasia

Imbalance between separase and securin levels in thyroid and other malignancies

ea0007p106 | Endocrine tumours and neoplasia

The effects of ghrelin on IGF-I expression in normal and malignant breast tissue explants

ea0007p107 | Endocrine tumours and neoplasia

Prevalence of hypopituitarism in patients with prolactin-secreting pituitary microadenomas

ea0007p108 | Endocrine tumours and neoplasia

Systemetic dose extension of octreotide LAR - the importance of individual tailoring of treatment

ea0007p109 | Endocrine tumours and neoplasia

Investigation into the efficacy of routine octreotide scanning in post-operative acromegalics with refractory disease

ea0007p110 | Endocrine tumours and neoplasia

Octreotide dependency: a cautionary tale

ea0007p111 | Endocrine tumours and neoplasia

Expression of SSTR subtypes (1-5) in normal and malignant colonic tissue

ea0007p112 | Endocrine tumours and neoplasia

Metastatic glucagonoma de-differentiated to an insulinoma: response to embolization

ea0007p113 | Endocrine tumours and neoplasia

Long acting somatostatin analogues administered by practice nurses: an audit

ea0007p114 | Endocrine tumours and neoplasia

Long-term remission following withdrawal of dopamine agonist therapy in subjects with microprolactinomas

ea0007p115 | Endocrine tumours and neoplasia

Expression and localisation of BAD and Akt in human breast cancer cell lines pre- and post-irradiation

ea0007p119 | Endocrine tumours and neoplasia

Bilateral laparoscopic adrenalectomy for ACTH-dependent Cushing's syndrome

ea0007p120 | Endocrine tumours and neoplasia

BIM-23244, a somatostatin analogue with high affinity for somatostatin receptors 2 and 5, inhibits endothelial proliferation in vitro

ea0007p121 | Endocrine tumours and neoplasia

Discrepancies between current consensus criteria for cure after transsphenoidal surgery for acromegaly

ea0007p122 | Endocrine tumours and neoplasia

Retrospective audit of bilateral adrenalectomies with reference to the occurrence of Nelson's syndrome

ea0007p123 | Endocrine tumours and neoplasia

Parathyroid imaging: which modality best inform surgical treatment?

ea0007p124 | Endocrine tumours and neoplasia

The efficacy of an octreotide test dose to predict the outcome of treatment for acromegaly with somatostatin LAR

ea0007p125 | Endocrine tumours and neoplasia

The changing patterns of presentation and treatment of acromegaly in the UK as reflected by the UK National Acromegaly Database

ea0007p126 | Endocrine tumours and neoplasia

Improved quality of life (QOL) with normalisation of IGF-I in patients with acromegaly

ea0007p127 | Endocrine tumours and neoplasia

24-hour ambulatory blood pressure monitoring (ABPM) in patients with acromegaly and the value of clinic blood pressure measurements

ea0007p128 | Endocrine tumours and neoplasia

23rd Joint Meeting of the British Endocrine Societies with the European Federation of Endocrine Societies

BiosciAbstracts